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Background: The phosphorylation of eIF4E plays 
a critical role in controlling protein translation. 
Results: MNV1 infection results in activation of 
p-eIF4E, its relocation to polysomes, and 
translational regulation. 
Conclusion: MNV1 manipulates the host cell 
translation machinery by controlling eIF4E 
activity. 
Significance: Regulation of cellular response to 
infection may contribute to viral pathogenesis and 
persistence.  
 
ABSTRACT 
    Protein synthesis is a tightly controlled 
process responding to several stimuli including 
viral infection. As obligate intracellular 
parasites, viruses depend on the translation 
machinery of the host and can manipulate it by 
affecting the availability and function of 
specific eukaryotic initiation factors (eIFs). 
Human norovirus (HuNV) is a member of the 
Caliciviridae family and is responsible for 
gastroenteritis outbreaks. Previous studies on 
feline calicivirus (FCV) and murine norovirus 1 
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(MNV1) demonstrated that the viral protein, 
genome linked (VPg), acts to direct translation 
by hijacking the host protein synthesis 
machinery. Here we report that MNV1 
infection modulates the MAPK pathway to 
activate eIF4E phosphorylation. Our results 
show that the activation of p38 and Mnk during 
MNV1 infection is important for MNV1 
replication. Furthermore, phosphorylated 
eIF4E relocates to the polysomes and this 
contributes to changes in the translational state 
of specific host mRNAs. We propose that global 
translational control of the host by eIF4E 
phosphorylation is a key component of the 
hostpathogen interaction. 
                                      
             
 Human norovirus (HuNV) is the major 
cause of non-bacterial gastroenteritis in the 
developed world (1-3). Worldwide, noroviruses 
are responsible for an estimated 218 000 deaths 
per annum in children under the age of five years 
and 1.1 million hospital admissions, with 
outbreaks often occurring in closed facilities such 
as hospitals (4). It is estimated that norovirus 
infection results in a loss of £110 million to the 
United Kingdom National Health Service every 
year owing to more than 45 000 hospital bed 
closures (5). The genogroup GII genotype 4 
(GII.4) strains are responsible for the majority of 
HuNV outbreaks, including pandemics, and were 
responsible for over one million cases in 201213 
in the United Kingdom alone (6).While norovirus 
infection mainly results in acute and self-resolving 
symptoms, it can also contribute to inflammatory 
bowel disease or neonatal enterocolitis (7-9), and 
has been reported to cause persistent infections in 
the immunocompromised and the elderly (10,11). 
The Norovirus genus is a member of the 
Caliciviridae family of viruses having a small 
single-stranded positive-sense RNA genome. 
Members of the Caliciviridae typically have 
genomes ranging from 7.3 to 8.3 kb in length that 
are polyadenylated at the 3 end but, unlike 
eukaryotic mRNAs, have a viral genome-linked 
protein (VPg) covalently attached at the 5 end. 
This raised questions about the molecular 
mechanisms for translation of the viral RNA (12). 
A detailed understanding of the replication cycle 
and pathogenesis of human noroviruses is limited 
owing to the lack of an efficient cell culture 
system to propagate the virus (13,14). However, 
the related caliciviruses murine norovirus (MNV1) 
and feline calicivirus (FCV) can be propagated in 
cell culture and are used as models that have 
helped to dissect the norovirus life cycle (15-17).       
 Viruses are obligate intracellular parasites 
and depend on the host translational machinery to 
produce viral proteins. Viral mRNAs have 
therefore evolved mechanisms to enable them to 
compete with the host mRNAs for cellular 
ribosomes and translation factors. Moreover, 
translational control enables the cell to adjust 
rapidly to its environment by regulating the 
translation rate of selected mRNAs and therefore 
provides an ideal strategy for delivering the 
targeted responses required during viral infection. 
Generally, translational control is exerted at the 
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initiation stage during which ribosomes are 
recruited to the 5 end of the cellular mRNA 
typically bearing a cap structure 7
Me
GpppN (18). 
The interaction between the ribosome and the 
mRNA is facilitated by the eukaryotic initiation 
factor (eIF) 4F complex consisting of eIF4E, the 
cap binding protein, eIF4G, a scaffolding protein, 
and eIF4A, an RNA helicase required to unwind 
RNA structure during ribosome scanning. Once 
eIF4F is bound to the cap, it acts as a point of 
attachment for ribosomes which then scan the 
messenger RNA to locate the AUG start codon 
and initiate translation (18). 
 Viruses can modulate translation by 
altering the function of eIFs. For example, this 
may be achieved by site-specific cleavage of 
eIF4G or the phosphorylation of eIF2 (19,20). 
Among the translation factors, eIF4E is thought to 
be limiting for translation, thus regulating the 
activity of eIF4E is critical for cellular function 
(21). The activity of eIF4E is regulated by the 
eIF4E-binding proteins (4E-BPs), which inhibit 
translation initiation by competing with eIF4G for 
a common binding site on eIF4E (22). The 
interaction of 4E-BP with eIF4E is prevented 
when 4E-BP is phosphorylated by mTOR, a 
downstream kinase within the phosphatidylinositol 
3 kinase-Akt-mammalian target of rapamycin 
(PI3K-Akt-mTOR) pathway (23,24).  Viruses can 
manipulate this pathway to regulate 4E-BP1 
phosphorylation and therefore eIF4E availability 
(20,25,26). For example, poliovirus and vesicular 
stomatitis virus (VSV) induce the 
dephosphorylation of 4E-BP1 to limit eIF4E 
availability and cellular translation (20). The 
activity of eIF4E is also controlled by its 
phosphorylation status. The mitogen activated 
protein kinase interacting kinases Mnk1/2 
phosphorylate Ser 209 of eIF4E (27). The control 
of eIF4E phosphorylation depends not only on the 
activation of Mnk1/2 by signalling cascades of the 
mitogen-associated protein kinases p38 and 
ERK1/2 (28), but also on the ability of Mnk1/2 to 
access eIF4E when both eIF4E and Mnk1/2 are 
bound to eIF4G (29-31). Infections with herpes 
simplex virus (HSV-1) and human 
cytomegalovirus (HCMV) both lead to an 
accumulation of phosphorylated eIF4E; while 
influenza virus, poliovirus and EMCV induce 
eIF4E dephosphorylation (reviewed in (19)). 
Although the consequence of eIF4E 
phosphorylation on its affinity for the cap remains 
the subject of debate, this has been shown to 
control the translation of specific mRNAs 
encoding proteins associated with cell 
proliferation, inflammation and interferon 
production (32-34).  
 The calicivirus RNA lacks the canonical 
cap structure recognized by eIF4E. However, 
previous studies have shown that the norovirus 
VPg proteins act as a “cap substitute” to mediate 
translation by interacting with initiation factors 
(35-38). Recently, we have shown that MNV1 
VPg directly binds to the eIF4F complex, and that 
this process is mediated by a high affinity 
interaction between eIF4G and the C-terminal 
domain of VPg (39). Although MNV1 VPg also 
interacts with eIF4E, the role of this interaction 
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remains to be discovered. The depletion of eIF4E 
or addition of 4E-BP1 have little to no impact on 
MNV1 VPg-linked RNA translation in rabbit 
reticulocyte lysates or in cells (38,39).  
 Based on these studies, we hypothesized 
that eIF4E could play an important role during the 
norovirus life cycle through the modulation of 
eIF4E phosphorylation mediated by the mitogen-
activated protein kinase (MAPK) pathway. To 
address this we have investigated the 
phosphorylation status of eIF4E in cells infected 
with the only norovirus that can undergo a 
complete replication cycle in cell culture, namely 
MNV1. Our results suggest that Mnk1 is 
responsible for the phosphorylation of eIF4E 
during MNV1 infection. Furthermore, we show 
that the activation of Mnk1 by the p38 kinase is 
important during the viral life-cycle because 
impairment of eIF4E phosphorylation by 
inhibition of these kinases has a deleterious effect 
on viral replication. Moreover, using polysomal 
profile analysis, we show that phosphorylated 
eIF4E relocates to the polysomes during infection 
and we provide evidence that this could induce the 
translational control of a subset of mRNAs during 
infection. These results suggest that regulation of 
eIF4E activity plays a role during MNV1 infection 
to regulate translation of specific host mRNAs.  
 
EXPERIMENTAL PROCEDURES 
Cells and viruses  Mouse leukaemic 
monocytemacrophage (RAW264.7) cells 
(ECACC) were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) with 4.5 gL1 D-
glucose + L-glutamine + pyruvate (Gibco, Life 
Technologies), supplemented with 10% (vol/vol) 
FBS, and 1% (vol/vol) penicillin/streptomycin 
(5000 units ml
1
 penicillin G sodium; 5000 µg 
ml
1
 streptomycin sulphate in 0.85% saline (Life 
Technologies)) at 37 °C in 5 % CO2. MNV1 strain 
CW1, propagated in RAW264.7 cells, was 
described previously (38). Virus titres were 
estimated by determination of the 50% tissue 
culture infectious dose (TCID50) units per ml. For 
a multiplicity of infection (MOI) equal to one, 
cells were infected with 1 TCID50 unit per cell. 
Infection time-course experiments  The day 
before infection, RAW264.7 cells were seeded in 
duplicate in 35-mm dishes at a density of ~3.5  
10
6
 cells per dish to obtain confluent monolayers. 
The RAW264.7 cells were infected with MNV1 at 
a MOI of 10 TCID50 per cell. Matched cell-free 
lysates were used for control mock infections. The 
cells were incubated with 5% carbon dioxide at 
37C.  Two-point time-courses for MNV infection 
were harvested at either 2 and 12 or 6 and 14 hpi. 
The cells were washed twice with 1 ml PBS before 
harvesting the cells in 100 µl NLB buffer (50 mM 
HEPES pH 7.4; 150 mM NaCl; 2 mM EDTA; 2 
mM Na3VO4; 25 mM disodium b-
glycerophosphate; complete protease inhibitor 
cocktail (Roche Applied Science; Burgess Hill, 
UK); 0.5% NP40), followed by centrifugation for 
3 min at 595  g in a benchtop centrifuge 
(Centurian 1000 Series, Centurion Scientific; East 
Preston, UK).  
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SDS-PAGE and Immunoblotting  Protein 
concentrations of the cell lysates were determined 
by bicinchoninic acid (BCA) assay using the 
Pierce BCA Protein Assay Kit (Thermo Scientific, 
Rockford IL USA) as per the manufacturer’s 
instructions. The samples were adjusted to the 
same concentration of between 20 to 50 g of 
protein and made up to 30 µl with NLB and SDS 
(3) sample buffer (New England BioLabs (NEB); 
Hitchin, UK). The proteins were then separated by 
SDS-PAGE (Mini Protean TGX gels; Bio-Rad, 
Hemel Hempstead UK) and transferred to 
polyvinylidene fluoride (PVDF) Immobilon-P 
membrane (Merck Millipore, Watford UK) for 
subsequent immunoblotting using conventional 
methods (40). Following incubation with primary 
antibodies, washes, and incubation with secondary 
antibodies, the membranes were probed for 
chemiluminescence using SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific) 
and the signal detected on radiographic film (Fuji 
RX; Fisher, Loughborough UK).  
Phospho-antibody array  The Proteome Profiler 
Human Phospho-MAPK Array (R&D Systems; 
Abingdon, UK) was used to analyse activation of 
ERK and p38 using 300 µg protein samples from 
lysates of mock- and MNV1-infected RAW264.7 
cells isolated at 2 and 12 hpi according to the 
manufacturer’s instructions.  The signal was 
detected on radiographic film (Fuji RX) and 
quantified using ImageJ software (NIH, Bethesda, 
MD USA).  
Antibodies and chemical inhibitors  Antibodies 
against eIF4E and MNV1 NS7 (41,42) have been 
described previously. Phospho-specific antibodies 
to eIF4E (Ser209), 4E-BP1 (T36/47; S65; T70); 
eIF2 (S52), Mnk1 (Thr197/202) and 
corresponding total antibodies were obtained from 
Cell Signaling Technology (NEB). Antibody to 
GAPDH was obtained from Ambion; Life 
Technologies (Paisley, UK). Secondary antibodies 
included anti-rabbit-HRP and anti-mouse-HRP 
(Dako; Cytomation, Ely, UK). All antibodies were 
used in accordance with the manufacturer’s 
instructions. The following chemical inhibitors 
were used for pathway analysis: SB203580 
(Calbiochem; Merck Millipore; Nottingham UK) 
targets p38/; SCH772984 (Calbiochem) targets 
ERK1/2; and CGP57380 (Tocris bioscience; 
Abingdon, UK) targets Mnk1. The inhibitor of the 
eIF4EeIF4G interaction, 4E2RCat, was kindly 
provided by Professor Jerry Pelletier (McGill 
University, Canada). Sodium arsenite was used to 
induce eIF2 alpha phosphorylation (30 min, 0.5 
mM). CellTiter-Glo® Luminescent Cell Viability 
Assay (Promega; Southampton, UK) was used to 
monitor cell viability over the range of 
concentrations used for each inhibitor according to 
the manufacturer’s instructions.  
Signalling pathway inhibition  The effect of 
signalling inhibitors on viral replication was 
determined by treating confluent monolayers of 
cells in 35-mm dishes with increasing 
concentrations of SCH772984 (ERK1/2; 1 to 20 
µM), CGP57380 (Mnk1; 1 to 20 µM) and 
SB203580 (p38; 1 to 25 µM), and incubating them 
for 1 h at 37 C with 5% CO2 as before. To 
measure the effect of inhibitors on eIF4E 
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phosphorylation, cells were stimulated with LPS at 
a concentration of 10 ng.µl
1
, harvested as before 
at 2 and 12 h after stimulation and analysed by 
Western blot. To measure the effect of inhibitors 
on viral replication, the cells were infected at a 
MOI of 0.3 TCID50 per cell with MNV1 for 1 h at 
RT. Following replacement of the virus-containing 
medium with fresh medium and inhibitor, the cells 
were incubated for a further 12 h at 37C with 5% 
CO2. Culture supernatants were retained and virus 
titre was estimated by determination of TCID50 as 
before.  
Polysome profile analysis  Separation of 
polysomes by sucrose density gradient 
ultracentrifugation was carried out as previously 
described (43). RAW264.7 cells (1-2 x 10
7
), mock 
or MNV1-infected (MOI of 6.7 TCID50 per cell) 
for 8 h, were incubated with 10 μg/ml 
cycloheximide (CHX) for 10 min at 37°C and 5% 
CO2. Cells were washed on ice with PBS 
containing 10 μg/ml CHX, harvested by scraping 
and spun at 450  g for 5 min at 4°C. The cell 
pellet was resuspended in 500 μl lysis buffer (20 
mM Tris pH 7.5, 300 mM sodium chloride, 15 
mM magnesium chloride, 100 μg.ml1 CHX and 
1% (v/v) Triton X-100) and the resulting lysates 
were clarified by centrifugation at 19 000  g for 5 
min at 4°C, frozen in liquid nitrogen and stored at 
80°C. To separate polysomes, samples were 
layered on to a 1050% sucrose gradient in lysis 
buffer and centrifuged in an SW40Ti rotor 
(Beckmann Coulter; High Wycombe, UK) at 38 
000 rpm for 2 h. Gradients were fractionated into 
1-ml fractions using a FoxyR1 collection system 
(Teledyne ISCO; Lincoln NE, USA) and UV 
absorbance was monitored at 254 nm. To induce 
run-off of polysomes, cycloheximide was omitted 
from the lysis and gradient buffers and replaced 
with 10 mM EDTA. Total RNA was extracted 
from cell lysates or polysomal fractions using the 
ZR RNA MiniPrep kit (Zymo Research, Irvine 
CA, USA) and analysed by agarose gel 
electrophoresis (1%, 1X TBE). To monitor the 
localisation of p-eIF4E in polysomal fractions, 
fractions 610 from each gradient were pooled and 
analysed by immunoblotting against eIF4E and p-
eIF4E. 
RNA isolation, PCR and quantitative real-time 
RT-PCR  Following polysomal fraction 
separation, each fraction was first spiked with an 
exogenous RNA reference, 50 ng of LysA mRNA 
from Bacillus subtillis as described before (44). 
Pooled polysomal fractions (typical fractions 59) 
or non-polysomal fractions were first concentrated 
using Amicon Ultra-4 centrifugal filter devices 
(YM-30; Millipore). Total RNA was extracted 
using ZR Miniprep RNA extraction columns 
following the manufacturer’s instructions and 
including an on-column TURBO DNase I 
digestion. Using RNA purified from the total RNA 
or polysome fractions, first strand cDNA synthesis 
was performed using equivalent amounts of 
starting RNA from all samples (First strand cDNA 
synthesis kit, Roche). For PCR analysis, the cDNA 
was analysed using the PCR Master Mix 
(Promega) and the PCR cycle conditions used 
were 95C for 5 min, followed by 30 cycles of 
 at U
N
IV
 O
F SU
RREY
 on January 30, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Control of eIF4E phosphorylation during MNV1 infection 
7 
 
95C for 30 s, 55C for 30 s and 72C for 1 min. 
The primer pairs used are described in Table 1. 
For qPCR analysis, the cDNA was analysed with 
the MESA BLUE qPCR MasterMix Plus for 
SYBR (Eurogentec, Southampton UK) using a 
Stratagene MX3005 (Stratagene; La Jolla CA, 
USA). All samples were prepared in triplicate. The 
PCR cycle conditions used were 95C for 5 min, 
followed by 40 cycles of 95C for 15 s and 60C 
for 1 min, and the Ct values determined using the 
MxPro software (Strategene). The translational 
state (TS) change was calculated after the 
abundance of each mRNA in monosomes and 
polysomes was normalized with respect to the 
abundance of the spiked-in control, then the 
changes in polysomes were normalized to the 
changes in monosomes for a given mRNA and the 
values are expressed as a function of the TS 
obtained for mock cells and set to 1.  
 
RESULTS 
eIF4E phosphorylation is important for 
MNV1 translation and replication  Previous 
studies have demonstrated that the VPg protein of 
caliciviruses acts as a proteinaceous cap substitute 
to initiate translation by interacting with eIF4E 
both in vitro and in vivo (37,38). However, while 
the interaction with eIF4E is required for the 
translation of FCV RNA in in vitro RRL systems, 
it plays little to no role in MNV translation in vitro 
or in murine microglial cells (38,39). Here we 
hypothesize that instead of a direct role in viral 
translation, eIF4E and/or the regulation of its 
activity might be important during MNV1 
replication. 4E2RCat has been identified by high-
throughput screening as an eIF4EeIF4G inhibitor 
with an IC50 of 13.5 M. It blocks cap-dependent 
translation in vitro and in cells, and inhibits 
coronavirus replication (45,46). Therefore, to 
determine whether there exists any requirement for 
the eIF4EeIF4G interaction during calicivirus 
replication, we investigated the effect of 4E2RCat 
on MNV1 replication. First we ascertained that 
4E2RCat did not affect the viability of the host 
cells. At the concentrations used in our studies, 
from 10 to 25 M, no effect was detected on 
RAW264.7 cell viability (Fig. 1A). In addition, we 
used cap-sepharose pull-down and 
immunoblotting as previously described (37,38) to 
show that increasing concentrations of 4E2RCat 
led to a reduction in the amount of eIF4G pulled 
down relative to eIF4E (Fig. 1B). A different 
inhibitor of the eIF4EeIF4G interaction, namely 
4EGI-1, has been shown to induce eIF2 
phosphorylation leading to decreased translation 
independently from its effect on eIF4E (47). We 
therefore verified, by immunoblotting, that 
4E2RCat did not induce eIF2 phosphorylation at 
the concentration used (Fig. 1C). We next 
measured the effect of 4E2RCat on MNV1 
replication by infecting RAW264.7 cells at a MOI 
of 0.3 TCID50 per cell with MNV1 for 12 h, and 
determining viral titre using a TCID50 assay. In the 
presence of 4E2RCat, the replication of MNV1 
was inhibited in a dose-dependent manner with 
significant inhibition of MNV replication at both 
15 and 25 M concentrations (Fig. 1D). This 
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suggests that impairing the interaction of eIF4E 
with eIF4G inhibits some aspect of the MNV1 life 
cycle.  
In addition to driving the formation of the eIF4F 
complex and translation, the formation of a 
complex between eIF4E and eIF4G is also 
important for the regulation of eIF4E 
phosphorylation (31,48). In response to various 
stimuli acting through signalling cascades of the 
mitogen-associated protein kinases p38 and ERK, 
the mitogen activated protein kinase interacting 
kinases, Mnk1/2, phosphorylate eIF4E on Ser 209 
(27). Importantly, Mnk1/2-mediated 
phosphorylation of eIF4E occurs only when eIF4E 
is complexed with eIF4G, as Mnk1/2 lack the 
ability to bind eIF4E directly (48). Several viral 
infections induce an accumulation of 
phosphorylated eIF4E that correlates with the 
inhibition of cellular protein synthesis, while other 
infections can lead to eIF4E dephosphorylation 
(20). Thus, after showing that perturbation of the 
interaction between eIF4E and eIF4G inhibits 
MNV1 replication, we investigated the 
phosphorylation status of eIF4E during MNV1 
infection. First, we evaluated the steady-state 
levels of eIF4E in cells infected with MNV1 by 
immunoblotting (Fig. 1E). The lysates from mock- 
and MNV1-infected RAW cells were fractionated 
by SDS PAGE and analyzed by immunoblotting at 
6 and 14 hpi time points of the 18-h replication 
cycle. The MNV1 infection is indicated by the 
presence of the viral NS7 protein. While there was 
no obvious change in the level of eIF4E during 
infection, the level of p-eIF4E increased (Fig. 1E). 
At 6 and 14 hpi the relative level of p-eIF4E 
increased from 1 to 1.56 and 1.98 when compared 
to the mock infection (Fig. 1E). Therefore, MNV1 
induces the phosphorylation of eIF4E. 
Furthermore this does not reflect a general, 
unspecific activation of intracellular signalling. 
Indeed, we could not detect any activation of 4E-
BP1 phosphorylation, which has been shown 
before to be a response to several viral infections 
(Fig. 1F). 
eIF4E phosphorylation via MAPK 
signalling pathways is important for MNV1 
replication  The MAPK pathway is responsible 
for phosphorylating eIF4E in response to external 
stimuli. The cellular kinases Mnk1/2 
phosphorylate eIF4E on Ser209, and while Mnk2 
is constitutively activated, Mnk1 is activated by 
either of the kinases p38 or ERK1/2, via MEK3/6 
and MEK1/2, respectively (27,29,49). To analyze 
the importance of eIF4E phosphorylation for 
MNV1 replication, we monitored Mnk1 activation 
during MNV1 infection. To this end, the lysates 
from mock- and MNV1-infected RAW264.7 cells, 
at 2 or 12 hpi, were fractionated by SDS PAGE 
and analysed by immmunoblotting. The steady-
state levels of Mnk1 in cells at 2 or 12 hpi were 
not affected by MNV1 infection (Fig. 2A). 
However, MNV1 infection led to an increase in 
Mnk1 phosphorylation (Fig. 2A). To further 
investigate the role of Mnk1 in eIF4E 
phosphorylation and its importance for MNV1 
replication, we analyzed the effect of inhibiting 
Mnk1 function. RAW264.7 cells were treated with 
1 to 20 M CGP57380, a specific inhibitor of 
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Mnk1. At these concentrations, this compound had 
no effect on cell viability, while impairing eIF4E 
phosphorylation (Fig. 2B and 2C). We treated 
RAW264.7 cells with CGP57380, and infected 
them for 12 h with MNV1 at a MOI of 0.3 TCID50 
per cell, and the virus titre was determined using 
TCID50 assay. The addition of 10 µM or 20 µM 
CGP57380 impaired MNV1 replication, 
significantly reducing viral titre by 60% and 67%, 
respectively (Fig. 2D). This suggested that Mnk1 
could play a role during MNV1 infection by 
phosphorylating eIF4E.  
The MAP kinases p38 and ERK1/2 can activate 
Mnk1 to regulate the phosphorylation of eIF4E. 
Therefore to consolidate our hypothesis that eIF4E 
phosphorylation contributes to the MNV1 life 
cycle, we used a MAPK antibody array to examine 
the activation of ERK1/2 and p38. Using the 
lysates of mock- and MNV1-infected RAW264.7 
cells we monitored the phosphorylation of ERK1 
and ERK2 and the different isoforms of p38 at 2 
and 12 hpi. These data, summarized in Fig. 3A, 
show that at both 2 and 12 hpi, ERK1 and ERK2 
are activated during MNV1 infection. In addition, 
the main p38 isoform, p38 shows strong 
activation during MNV1 infection, and similarly 
for p38, whereas p38and p38 showed no 
significant change. To further dissect whether the 
activation of p38 and ERK1/2 may be required for 
MNV1 replication, we used chemical inhibitors of 
p38 and ERK1/2 kinase activity, SB203580 and 
SCH772984 respectively. First, we ensured that at 
the concentrations tested, the inhibitors did not 
affect cell viability (Fig. 3B and C), and that they 
reduced eIF4E phosphorylation (Fig. 3D). 
RAW264.7 cells were then treated with SB203580 
or SCH772984, and infected at a MOI of 0.3 
TCID50 per cell with MNV1 for 12 h, and the virus 
titre was estimated by determination of TCID50. 
The addition of SB203580 resulted in a dose-
dependent reduction of eIF4E phosphorylation and 
MNV1 titre, with an 82% inhibition of replication 
at 25 µM (Fig. 3D and 3E). The addition of 
SCH772984 also impaired the phosphorylation of 
eIF4E (Fig. 3D). However, we could not detect 
any significant effect on MNV1 replication upon 
ERK1/2 inhibition (Fig.3F). This might be due to 
the differential effect of p38 and ERK on Mnk1 
activation. Indeed, while ERK1/2 can activate both 
Mnk2, responsible for constitutive eIF4E 
phosphorylation and Mnk1, responsible for 
inducible eIF4E phosphorylation, p38 selectively 
targets Mnk1 (50). These results demonstrate that 
MNV1 infection triggers the activation of Mnk1 
and that while both upstream kinases ERK and 
p38 are activated, only the activation of p38 is 
required for MNV1 replication. To support this, 
RAW264.7 cells were then treated with 
SCH772984, and infected at a MOI of 0.3 TCID50 
per cell with MNV1 for 12 h, and the 
phosphorylation of eIF4E monitored by 
immunoblotting. The addition of SCH772984 did 
prevent eIF4E phosphorylation during infection 
(Fig.3G). These data further support a role for 
eIF4E phosphorylation during infection, driven by 
p38 rather than ERK.  
 p-eIF4E relocates to polysomes during 
MNV1 infection   It has been shown that p-eIF4E 
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is involved in the translational control of specific 
mRNAs involved in cell survival and 
inflammation (32,51,52). Moreover, a recent study 
demonstrated that p-eIF4E regulates interferon 
production by controlling the translation of Nfkbia 
mRNA, thereby modulating sensitivity to viral 
infections (33). Thus, we hypothesized that p-
eIF4E could play a role during MNV1 infection by 
altering the translation of a subset of mRNAs. 
Therefore, we used polysome analysis to isolate 
the mRNAs associated with translationally active 
ribosomes in MNV1-infected cells. First, cell 
lysates from mock or MNV1-infected cells at 8 hpi 
(representing an early time during infection with 
ongoing RNA and protein synthesis) were 
prepared and subjected to a 10–50% sucrose 
gradient centrifugation. A typical polysome profile 
pattern was obtained as shown in Figure 4A. In 
contrast to the mock-infected cells, MNV1-
infected cells exhibited a moderate translational 
defect as shown by a decrease in the amount of 
polysomes (Fig. 4A). This was further quantified 
by monitoring the ratio of polysomes to 
monosomes. Quantification of the areas under the 
monosome and polysome peaks shows that the 
polysome/monosome (P/M) ratio of MNV1-
infected cells is 74% that of mock-infected cells 
(Fig. 4B). Thus, a fraction of free ribosomal 
subunits is no longer engaged in mRNA 
translation during MNV1 infection, which could 
suggest a moderate general inhibition of mRNA 
translation. Subsequently, we analysed the 
association of p-eIF4E with translationally active 
polysomes. We observed that the amount of total 
eIF4E in both total lysates and in pooled 
polysomal fractions was similar in mock- and 
MNV1-infected cells (Fig. 4C). However, we 
found that p-eIF4E was associated with polysomal 
fractions from MNV1-infected cells but not mock-
infected cells (Fig. 4C). The association of p-
eIF4E with polysomes was impaired when run-off 
of polysomes was induced with EDTA, suggesting 
that p-eIF4E does not sediment with high-density 
complexes in the absence of polysomes (Fig. 4C). 
These results suggest that p-eIF4E relocates to 
polysomes during MNV infection and support the 
idea that the phosphorylation of eIF4E contributes 
to the viral life cycle. To further investigate 
whether translation of specific mRNAs is altered 
during MNV1 infection in order to modulate the 
hostpathogen interactions, we analysed mRNA 
translation status using RT-qPCR. To address this, 
we compared the relative abundance of a set of 
mRNAs, including the p-eIF4E sensitive Nfkbia 
mRNA, and other mRNAs previously proposed to 
be controlled by p-eIF4E (SRp20, CDK9, Casp4, 
rpS19, rpL32) in the pooled polysomal and non-
polysomal fractions in mock and MNV-1 infected 
cells to define their translational state (TS) (53). 
First, using RT-PCR, we were able to detect the 
presence of a control mRNA, GAPDH, in 
polysomes of both mock and MNV1-infected cell 
lysates, while MNV1 RNA was only detected in 
infected lysates (Fig. 5A). Then, we measured the 
abundance of target mRNAs, in pooled polysome 
or non-polysome fractions, using RT-qPCR. The 
changes in abundance in polysome and non-
polysome fractions were normalized to a spiked-in 
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exogenous RNA control and the TS represents the 
relative changes in abundance in polysome 
fractions normalized to changes in non-polysome 
fractions for a given mRNA during infection (Fig. 
5B). Using this analysis a TS>1 represents a 
translational activation of a particular mRNA 
while a TS<1 represents translational repression. 
Our results revealed that during MNV1 infection, 
Nfkbia mRNA is translationally activated (TS= 
2.2). This could correlate with the relocation of p-
eIF4E to polysome fractions as previous studies 
have demonstrated that the translational activation 
of Nfkbia mRNA is dependent on p-eIF4E (33). 
This in turn impairs interferon production by 
upregulating the translation of the NF-B inhibitor 
IB and leads to increased sensitivity to viral 
infection (33). Therefore, the stimulation of 
polysome associated phosphorylated eIF4E might 
reflect one mechanism by which MNV1 dampens 
the response of the cell to the infection. 
Furthermore, rpS19 and rpL32 were also 
translationally activated (TS=2.04 and 1.93 
respectively). No activation was detected for 
CDK9, Casp4 and SRp20 which could reflect that 
p-eIF4E alone is not sufficient for their 
translational activation and that additional cellular 
factors might be required. Other mRNAs such as 
mTOR, GAPDH or eIF4B were unaffected. 
Therefore, MNV1 infection leads to relocation of 
p-eIF4E to polysomal fractions and changes in the 
translational state of specific mRNAs.  
 
DISCUSSION  
 Caliciviruses have developed strategies to 
divert the host-cell translation apparatus to their 
mRNAs using the VPg protein, attached at their 5 
end, which acts as a cap substitute by interacting 
with eukaryotic initiation factors (35,37-39,54). 
The FCV VPg binds directly to eIF4E to direct 
translation in vitro (37). While an interaction 
between the MNV1 VPg and eIF4E has been 
demonstrated, its relevance for MNV1 translation 
remained unknown as it can be removed or 
sequestered in vitro with little to no impact on 
MNV translation (38). We have recently 
demonstrated that translation of the MNV1 RNA 
is driven by a high affinity interaction between 
eIF4G and the C-terminal domain of VPg (39). In 
addition, the siRNA-mediated reduction of eIF4E 
expression or its depletion through the 
overexpression of 4E-BP1 had no effect on MNV1 
replication (39). Several viruses manipulate 
signalling pathways to alter 4E-BP1 
phosphorylation and eIF4E availability, while 
eIF4E phosphorylation itself has been shown to be 
important for the replication of some viruses 
(20,55). For example, VSV infection results in the 
dephosphorylation of eIF4E and 4E-BP1, whereas 
eIF4E phosphorylation enhances HSV-1 
replication (56,57). This prompted us to 
investigate how calicivirus infection may 
influence eIF4E activity. We began by 
investigating the effect on MNV1 replication of 
4E2RCat, a molecule that prevents the interaction 
between eIF4E (the cap-binding protein) and 
eIF4G (the eIF4F large scaffolding protein) and 
impairs coronavirus replication (45,58). We found 
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that disruption of the eIF4EeIF4G interaction 
adversely affected the replication of MNV1 (Fig. 
1). Therefore, eIF4E, via its interaction with 
eIF4G, plays a role during MNV1 replication, 
either directly or indirectly.  
 It has been proposed previously that Mnk-
mediated eIF4E phosphorylation depends not only 
on the activation of Mnk itself but also on the 
accessibility of eIF4E through the recruitment of 
eIF4E to the eIF4G-Mnk complex (29,31). In fact, 
restricting Mnk access to eIF4E via the eIF4E 
inhibitor 4E-binding proteins, 4E-BPs, limits the 
phosphorylation of eIF4E (31). Therefore, we 
investigated whether the requirement for the 
eIF4EeIF4G interaction was important because it 
mediates eIF4E phosphorylation during MNV1 
infection, rather than for any direct role during 
viral translation. We detected little change in the 
level of total eIF4E during MNV1 infection, while 
the level of phosphorylated eIF4E increased 
during MNV1 infection (Fig. 2). By modulating 
MAPK pathways viruses can control eIF4E 
phosphorylation as seen with reovirus, HSV-1 or 
HCV (59-61). The MAP kinase-interacting kinases 
Mnk-1/2 phosphorylate eIF4E on the conserved 
physiological site at serine 209 upon their 
activation by MEK1/2 via ERK1/2, and p38 
(62,63). In agreement with our observation that 
eIF4E phosphorylation increases during infection, 
we also detected activation of Mnk1, ERK1/2 and 
p38 phosphorylation (Fig. 2 and 3). Furthermore, 
inhibition of the signalling pathways governing 
phosphorylation of eIF4E using inhibitors of p38 
(SB203580) and Mnk1 (CGP57380) caused a 
significant decrease in the replication of MNV1 
whereas the inhibition of ERK1/2 had no effect 
(Figs 2 and 3). This implies that although both the 
p38 and ERK arms of the MAPK pathway 
contribute to Mnk1/2 and eIF4E phosphorylation 
during MNV1 infection only p38 is required for 
viral replication.  
 Although the effect of eIF4E 
phosphorylation on its affinity for the cap remains 
the subject of research, phosphorylation of serine 
209 has been linked with cell survival and 
proliferation in a number of cancers, including 
prostate cancer (32,34,51,64,65). It has been 
proposed that p-eIF4E can stimulate the translation 
of specific mRNAs, including mRNAs involved in 
proliferation and the inhibition of apoptosis, but 
also in the control of inflammation and interferon 
production (32,33,52). For example, Mnk1 
activation and eIF4E phosphorylation can promote 
the synthesis of IRF8 and the expression of M1-
macrophage-associated genes (52). Furthermore, 
the loss of eIF4E phosphorylation in cells 
expressing the eIF4E mutant S209A, is associated 
with impaired translation of the Nfkbia mRNA 
which encodes the NF-B inhibitor IB this 
leads to an enhanced type I IFN response that 
protects against viral infection (33). Fitting with 
this observation, viral infections known to cause 
dephosphorylation of eIF4E (e.g. vesicular 
stomatitis virus) result in a reduced polysomal 
loading of Nfkbia mRNA and activation of NF-B 
which leads to interferon production (33). This 
highlights a direct involvement of eIF4E 
phosphorylation and translational control of a 
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subset of mRNAs in the host response to infection. 
The fractionation of polysomes from MNV1 or 
mock-infected cells supports a role for p-eIF4E in 
the translation of specific mRNAs during MNV1 
infection. Indeed, while the amount of polysomes 
decreased during infection to 75% (Fig. 4), which 
could represent a drop in overall translation 
(Emmot and Goodfellow in preparation), we 
observed an accumulation of phosphorylated 
eIF4E in polysomes (Fig. 4). This was not the case 
for the mock infection where no such 
accumulation was observed. Thus, it appears that 
MNV1 may induce eIF4E phosphorylation to 
maintain cell proliferation during infection or to 
control the translation of specific mRNAs 
involved in the antiviral response. Supporting this 
hypothesis we showed that the expression of the 
Nfkbia mRNA, sensitive to eIF4E 
phosphorylation, was upregulated during infection 
(Fig. 5). In addition, other p-eIF4E sensitive 
mRNAs, rpS19 and rpL32, were translationally 
activated, but not all. This would support a model 
in which additional factors, like RNA-binding 
proteins or miRNAs, would contribute to the 
translational activation of p-eIF4E sensitive 
mRNAs in a specific biological context.    
 MNV is an enteric pathogen that is 
interferon-sensitive and infects macrophages and 
dendritic cells in vivo sometimes resulting in long-
term persistent infections that are lifelong and 
occur despite the presence of an antibody and 
cellular immune response (66-68). Therefore, it is 
likely that MNV uses several strategies to avoid or 
control the cellular response to infection. Type-I 
interferons (IFN and IFN) are widely expressed 
cytokines that constitute a major component of the 
innate immune system, acting as the first line of 
defence against virus infections (69). IFN can 
elicit distinct and specific upstream signals to 
modulate translation and is highly sensitive to 
eIF4E availability (70,71). The only innate 
antagonist identified to date, VF1, appears to 
regulate activation of the innate immune response 
by antagonising the induction of IFN and 
delaying apoptosis (72). Like many viruses, it is 
likely that MNV has evolved several mechanisms 
to control the host response to infection due to the 
redundancy of the innate immune response to 
infection. Fitting with this hypothesis, the NS1/2 
and VP2 proteins have recently been shown to 
contribute to viral persistence (67,73). Here we 
describe an additional mechanism by which MNV 
infection may regulate the response to infection, 
namely the regulation of eIF4E activity, which is 
supported by the fact that the phosphorylation of 
eIF4E negatively regulates interferon production 
(33). Human astrovirus, another positive-sense 
single-stranded RNA virus encoding a VPg 
essential for viral infectivity, also activates 
ERK1/2 and inhibition of MEK1/2 significantly 
impairs viral replication (74,75). Controlling 
eIF4E phosphorylation could therefore be a more 
general mechanism that RNA viruses use to 
modulate translation during infection and control 
the host response to infection.  
 Overall, several of our results suggest that 
p-eIF4E plays a key role during MNV1 
replication: MNV replication is impaired 
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following disruption of the eIF4EeIF4G 
interaction, blocking the signalling pathways 
leading to eIF4E phosphorylation inhibits 
replication, and phosphorylated eIF4E relocates to 
polysomes during infection. However, the impact 
of the eIF4EVPg interaction observed before on 
these remains unclear. Independently from its cap-
binding activity, eIF4E exhibits an additional 
function and stimulates eIF4A helicase activity 
which can mediate mRNA restructuring (76). As 
eIF4A is required for MNV1 translation, the role 
of eIF4E recruitment to VPg could be to ensure 
optimal helicase activity and unwinding of the 
structured 5′ region of the MNV1 genome while 
the role of a potential interaction between p-eIF4E 
and VPg during infection is under investigation 
(38). To integrate all these data, we propose that 
the eIF4EeIF4G interaction is important to 
ensure that eIF4E can be efficiently 
phosphorylated via the ERK and p38 pathways 
during MNV1 infection since the phosphorylation 
of eIF4G-bound eIF4E requires the interaction of 
Mnk1/2 with eIF4G (48). This would therefore 
explain why both the eIF4EeIF4G interaction and 
the activation of the MAPK signalling pathways 
are required for MNV1 replication, while eIF4E 
does not play a direct role in viral translation. The 
association of phosphorylated eIF4E with actively 
translating ribosomes during MNV infection could 
facilitate the translation of as yet unidentified 
cellular mRNAs, including Nfkbia, to modulate the 
immune response as suggested by Herdy et al (33). 
Our findings support a model in which one of the 
mechanisms used by caliciviruses to control 
cellular translation during infection is to modulate 
the phosphorylation of eIF4E through the MAPK 
cell signalling pathways to ensure survival within 
the host. 
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FIGURE LEGENDS 
FIGURE 1. The eIF4EeIF4G interaction is important for calicivirus replication.  (A) Cell viability in 
the presence of 4E2Rcat, an inhibitor of the eIF4EeIF4G interaction, was determined using CellTiter-
Glo® Luminescent Cell Viability Assay (Promega). Viability is expressed as a percentage of the DMSO 
control set to 100%.  Results show the means +/ SEM from three separate experiments. (B) The efficacy 
of cap sepharose pull-down in the presence of 4E2Rcat was determined using immunoblotting for eIF4E 
and eIF4G. The efficacy of eIF4G pull-down is expressed as a percentage of the DMSO control set to 
100% and normalized to the eIF4E pull-down efficacy. Experiments were analysed by one-way ANOVA 
with Dunnett’s multiple comparisons test: *P<0.05; **P<0.01; ***P<0.001; ns not significant (GraphPad 
Prism 6; GraphPad software, San Diego, CA, USA). (C) RAW264.7 cells were pre-treated for 1 h with 10 
– 25 M 4E2RCat or 30 min with 0.5 mM sodium arsenite (Ars). Cell lysates were analysed by 
immunoblotting and results shown are representative of three independent experiments. (D) RAW264.7 
cells were pre-treated for 1 h with 10 – 25 M 4E2RCat. The RAW264.7 cells were subsequently infected 
at a MOI of 0.3 TCID50 per cell with MNV1. The figure shows the results of three separate experiments 
analysed by one-way ANOVA with Dunnett’s multiple comparisons test: *P<0.05; **P<0.01; 
***P<0.001; ns not significant (GraphPad Prism 6). (E) RAW264.7 cells were infected with MNV1 at a 
MOI of 10 TCID50 per cell and harvested at 6 and 14 hpi. Cell lysates were analysed by immunoblotting. 
The infection was monitored by visualisation of the viral non-structural protein-7 (NS7), the 3D 
polymerase. GAPDH was used as a loading control. The results were analysed by ImageJ software (NIH) 
and levels of eIF4E phosphorylation relative to uninfected cells at 6 hpi are shown +/ SEM. (F) 
RAW264.7 cells were infected with MNV1 at a MOI of 10 TCID50 per cell and harvested at 6 and 14 hpi. 
Cell lysates were analysed by immunoblotting. GAPDH was used as a loading control.  
FIGURE 2. eIF4E phosphorylation by Mnk1 is important for MNV1 replication. (A) RAW264.7 cells 
were infected with MNV1 at a MOI of 0.3 TCID50 per cell or mock-infected and lysates were harvested at 
2 and 12 hpi and analysed by SDS-PAGE and Western blotting. (B) RAW264.7 cells were treated with 
CGP57380, a specific Mnk1 inhibitor, at the indicated concentrations and cell viability was measured 
using the CellTiter-Glo® Luminescent Cell Viability Assay (Promega). (C) Similarly treated RAW264.7 
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cells were analysed by SDS-PAGE and Western blot for eIF4E. (D) RAW264.7 cells were subsequently 
treated with CGP57380 for 1 h before being infected with MNV1 at a MOI of 0.3 TCID50 per cell. The 
cells were incubated at 37C with 5% CO2 for 12 h and the viral titre was estimated by TCID50 assay.  
FIGURE 3. MAPK signalling through p38 is important for MNV1 replication. (A) The Proteome Profiler 
Human Phospho-MAPK Array (R&D Systems) was used to compare relative quantities of 
phosphorylated ERK and p38 between 2 and 12 hpi. The arrays were visualised by immunoblotting and 
the results were analysed using ImageJ software. The spots were normalised to control spots on the arrays 
and values for relative phosphorylation (activation) of the ERK and p38 isoforms are subsequently 
presented as relative pixel density. Viability of cells treated with SB203580 (p38) and SCH772984 (ERK) 
inhibitors was measured using CellTiter-Glo® Luminescent Cell Viability Assay (Promega) (B) and (C) 
respectively. Viability is expressed as a percentage of the DMSO control set to 100%. Results show the 
means +/ SEM from three separate experiments. (D) RAW264.7 cells were treated with SB203580 
(125 M) or SCH772984(120 M) for 1h as indicated before stimulating with LPS (10 ng/mL). Cell 
lysates were analysed by SDS-PAGE and Western Blot. (E) RAW264.7 cells were treated with the same 
range of concentrations of inhibitor as used for the viability assay with SB203580, and then incubated at 
37 C with 5% CO2 for 1 h before infection with MNV1 at a MOI of 0.3 TCID50 per cell. Cells were 
harvested at 12 hpi and the virus titre estimated by TCID50. (F) RAW264.7 cells were treated similarly 
with SCH772984 inhibitor at the indicated concentrations, infected with MNV1, and again MNV1 titre 
was estimated by determination of TCID50 at 12 hpi. The figure shows the results of three separate 
experiments analysed by one-way ANOVA with Dunnett’s multiple comparisons test: *P<0.05; 
**P<0.01; ***P<0.001; ns not significant (GraphPad Prism 6). (G) RAW264.7 cells were treated 
similarly with SCH772984 inhibitor at the indicated concentrations, infected with MNV1, and cell lysates 
were analysed by SDS-PAGE and Western Blot. 
 
FIGURE 4. Polyribosome analysis of mock- or MNV1-infected cells. (A) Lysates from mock-infected or 
MNV1-infected (MOI of 6.7 TCID50 per cell) RAW264.7 cells were prepared as detailed in the 
experimental procedures following 8 h of infection. A normalized (by A254) amount of lysate was 
separated on a 10-50% sucrose gradient and fractionated into 1-ml fractions using a FoxyR1 collection 
system (Teledyne). The displayed trace represents absorbance at 254 nm (vertical axis) throughout the 
gradient from top (left) to bottom (right). 40S (small ribosomal subunit), 60S (large ribosomal subunit), 
80S (monosome), and polysome peaks are labelled. (B) The areas underneath the monosome and 
polysome peaks were determined for several biological replicates (n = 3) and the mean 
polysome/monosome (P/M) ratio was calculated and normalized (as a percentage of the mock infected). 
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The ratio of the area under the polysomal (P) to monosomal (M) peaks is shown (P/M), calculated using 
standard AUC methods. (C)  Analysis by immunoblotting of the protein recovered from the profiling 
assay shows that phosphorylated eIF4E is detected only in the polysomal fractions (fractions 610 from 
the gradient) from MNV1-infected lysates. Polysome run-off was induced as indicated using EDTA. 
Results are representative of three separate experiments.  
 
FIGURE 5. Analysis of changes in translation state (TS) during MNV1 infection. (A) Semiquantitative 
RT-PCR analysis of GAPDH and MNV1 mRNA among total RNA isolated from the polysomal fractions 
of mock or MNV1 infected cells. Total RNAs were isolated from the pooled translationally active 
polysomal fraction and inactive free fraction of mock- or MNV1-infected cell lysates and subjected to 
reverse transcription using the Transcriptor first strand cDNA synthesis kit (Roche). PCR amplification 
was carried out using PCR Master Mix (Promega). (B) Status of polysomal and nonpolysomal 
abundances of mRNAs upon MNV1 infection. Total RNAs were isolated from the translationally active 
polysomal fraction and inactive free fraction of mock- or MNV1-infected cell lysates and subjected to 
reverse transcription using a Transcriptor first strand cDNA synthesis kit (Roche). PCR amplification was 
carried out using MESA BLUE qPCR MasterMix Plus for SYBR (Eurogentec) and an Mx3005 qPCR 
system (Stratagene). Shown are qPCR results from three independent biological isolates of both mock and 
MNV1-infected cells. The bars represent the mean and the error bars the SEM. The change in TS has 
been calculated using the formula [(mock/MNV1)poly/(mock/MNV1)mono], where (mock/MNV1)poly and 
(mock/MNV1)mono represent the changes of individual mRNAs in polysomal and monosomal RNA, 
respectively. 
 
TABLE 1: primer pairs used for PCR or qPCR amplification.  
Name           Forward primer (5’-3’); Reverse primer (5’-3’) 
of gene     
4EBP1         TAGCCCTACCAGCGATGAGCCT; GTATCAACAGAGGCACAAGGAGGTAT 
18S              AGTCCCTGCCCTTTGTACACA; GATCCGAGGGCCTCACTAAAC 
GAPDH      TTCAACGGCACAGTCAAGG; CTCAGCACCGGCCTCACC 
mTOR         GCAATAAGCGGTCCCGGACAA; GCTTTCTTATGGGCTGGTTCTCCAA  
eIF4B          ATGCGTGGGTGAAGCGAAGCTCT; GCTCAGGCGCAGATCTGGAGTC 
nfkbia          GACGCAGACCTGCACACCCC; TGGAGGGCTGTCCGGCCATT 
SRp20         TGAGGATCCCCGAGATGCT; CTTACACGGCAGCCACACAGT 
 at U
N
IV
 O
F SU
RREY
 on January 30, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Control of eIF4E phosphorylation during MNV1 infection 
24 
 
rpS19          CAGCACGGCACCTGTACCT; GCTGGGTCTGACACCGTTTC 
rpL32          CACCAGTCAGACCGATATGTGAAAA; TGTTGTCAATGCCTCTGGGTTT 
Casp4         CTCTGAGGCTCTTTCCAACG; TTCCAACACCTTAAGTGGCTTT 
cdk9           TGCAAGGGCAGCATCTATC; TCATGTCCCTGTGCAGGAT 
MNV1       CACGCCACCGATCTGTTCTG; GCGCTGCGCCATCACTC 
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